Stocks and Investing Stocks and Investing
Tue, August 6, 2024
[ 12:00 AM ] - WOPRAI
Grace Carter Maintained (THG) at Hold with Decreased Target to $158 on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Matthew Smith Maintained (THS) at Hold with Increased Target to $41 on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Andrew Lazar Maintained (THS) at Hold with Increased Target to $39 on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Daniel Chan Downgraded (TIXT) to Hold and Decreased Target to $3.75 on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Bernie McTernan Reiterated (SSTK) at Strong Buy and Held Target at $65 on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Reiterated (SPRO) at Strong Buy and Held Target at $7 on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Louise Chen Reiterated (SPRO) at Buy on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Ritu Baral Upgraded (SPRO) to Strong Buy on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
David Koning Downgraded (TWKS) to Hold and Held Target at $4.4 on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Tien-Tsin Huang Downgraded (TWKS) to Hold on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Arvind Ramnani Maintained (TWKS) at Hold with Increased Target to $4.4 on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Trey Grooms Reiterated (SUM) at Buy and Held Target at $47 on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Michael Legg Reiterated (SXI) at Strong Buy and Held Target at $210 on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Ryan MacDonald Reiterated (TALK) at Hold on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Samik Chatterjee Maintained (SMCI) at Buy with Decreased Target to $95 on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Mark Zgutowicz Reiterated (SNAP) at Hold on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Anupam Rama Maintained (SNDX) at Buy with Decreased Target to $33 on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Steve Sakwa Maintained (SPG) at Hold with Increased Target to $155 on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Simon Yarmak Maintained (SPG) at Strong Buy with Increased Target to $158 on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Eric Luebchow Maintained (DBRG) at Buy with Decreased Target to $18 on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Walter Spracklin Reiterated (CSX) at Hold and Held Target at $36 on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Fadi Chamoun Reiterated (CSX) at Buy and Held Target at $40 on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Brian Ossenbeck Maintained (CSX) at Buy with Increased Target to $42 on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Daniel Imbro Reiterated (CSX) at Buy and Held Target at $42 on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Ryan MacDonald Reiterated (CHGG) at Hold on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Arvind Ramnani Maintained (CHGG) at Sell with Decreased Target to $2 on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Mike Grondahl Maintained (CHGG) at Hold with Decreased Target to $6 on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Josh Baer Maintained (CHGG) at Hold with Decreased Target to $3 on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Eric Sheridan Upgraded (CHGG) to Hold and Decreased Target to $3.75 on, Aug 6th, 2024
[ 12:00 AM ] - WOPRAI
Etzer Darout Reiterated (CCCC) at Buy and Held Target at $20 on, Aug 6th, 2024

Etzer Darout Reiterated (CCCC) at Buy and Held Target at $20 on, Aug 6th, 2024


Published on 2024-10-28 13:14:06 - WOPRAI, Etzer Darout
  Print publication without navigation


Etzer Darout of BMO Capital, Reiterated "C4 Therapeutics, Inc." (CCCC) at Buy and Held Target at $20 on, Aug 6th, 2024.

Etzer has made no other calls on CCCC in the last 4 months.



There are 2 other peers that have a rating on CCCC. Out of the 2 peers that are also analyzing CCCC, 1 agrees with Etzer's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Derek Archila of "Wells Fargo" Maintained at Hold with Increased Target to $8 on, Thursday, May 9th, 2024


This is the rating of the analyst that currently disagrees with Etzer

  • Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $14 on, Thursday, May 9th, 2024
Contributing Sources